Inogen Inc
INGN· Nasdaq
Released Feb 27, 2024, after the close
10-K filed Mar 1, 2024, 61 days after period end · 0000950170-24-023820
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $123.46M | $73.18M | $63.37M | $73.98M |
| Net Income | -$26.56M | -$56.61M |
Inogen Inc · CIK 1294133 · Engraved from SEC EDGAR
| -$22.88M |
| -$5.12M |
| EPS Diluted | — | — | — | -$0.23 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.